Idk why you keep saying that old data is useless, as if bringing that up actually means anything. The point of a phase 2b is to get new data.
You can think what you like, but I still believe in PMCB & CIAB. I don't think I've ever heard one positive thing from you about Pharmacyte. You post here everyday, but that's none of my business. I don't know what your motives are and I don't care.
IND is what we wait for, even if it takes a year, PMCB will get there. I am just able to evaluate both the positives and the negatives. The positives outweigh the negatives IMO and the reward is worth the risk.
News 
Market Data 
Discover 
